Vigil Neuroscience, Inc.
VIGL
Revenue
0.00
0.000.00%
-Assets
108.46M
▼-16.61M▼-13.28%
3 Months ChangeLiabilities
23.19M
▲1.90M▲8.90%
3 Months ChangeFree Cash Flow
-22.68M
▼-4.39M▼-24.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 8-K
ID: 0001193125-24-220131
2024-08-13
Form 10-Q
ID: 0000950170-24-095755
2024-08-13
Form 8-K
ID: 0001193125-24-199396
2024-07-24
Form 8-K
ID: 0001193125-24-183318
2024-07-18
Form 8-K
ID: 0001193125-24-180727
2024-06-27
Form 8-K
ID: 0001193125-24-170520
2024-06-06
Form 8-K
ID: 0001193125-24-156044
2024-05-07
Form 10-Q
ID: 0000950170-24-054623
2024-05-07
Form 8-K
ID: 0001193125-24-133141
2024-03-26
Form 8-K
ID: 0001193125-24-077088